L'UE débat actuellement pour savoir si elle doit dévoiler sa nouvelle stratégie de sécurité avant ou après le sommet de l'OTAN prévu en juillet.
The post L’UE débat du moment opportun pour dévoiler sa nouvelle stratégie de sécurité appeared first on Euractiv FR.
Written by Laurence Amand-Eeckhout.
CONTEXTOn 16 December 2025, the European Commission put forward a proposal for a regulation to simplify the rules governing medical devices in the EU. The proposal forms part of a broader package of measures aimed at improving citizens’ health and strengthening the resilience and competitiveness of the health sector. An evaluation of the current EU regulatory framework for medical devices concluded that it has led to unnecessary costs, administrative bottlenecks, regulatory uncertainty for companies, and delays in patient access to medical devices. The proposed revision seeks to address these challenges while ensuring that patient safety remains the highest priority, with faster access to safe and innovative devices. It also aims to reinforce the EU’s competitiveness in the medical technology sector, by establishing a more coherent framework enabling companies to better respond to evolving market conditions, technological developments and patient needs.
LEGISLATIVE PROPOSAL2025/0404(COD) – Proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I – COM(2025) 1023, 16 December 2025.
NEXT STEPS IN THE EUROPEAN PARLIAMENTFor the latest developments in this legislative procedure, see the Legislative Train Schedule: 2025/0404(COD)
Read the complete briefing on ‘Medical devices: Simplifying the rules‘ in the Think Tank pages of the European Parliament.
« Nous voulons utiliser nos superpouvoirs pour la médecine d'une manière différente », ont-ils déclaré.
The post Les fondateurs de BioNTech quittent leurs fonctions de PDG pour développer des thérapies à base d’ARNm alimentées par l’IA appeared first on Euractiv FR.
Le projet de proposition de la Commission pour le 28e régime, consulté par Euractiv, opte pour un raccourci innovant mais risqué sur le plan juridique.
The post EXCLUSIF : La Commission va proposer un réglement pour un droit unique des sociétés en Europe appeared first on Euractiv FR.